Trial intelligence / Profile preview

Dexmedetomidine for postoperative pulmonary function in totally thoracoscopic cardiac surgery

ChiCTR2000032652Phase 4Completed

Sponsor
Guangdong Provincial People's Hospital Zhuhai Hospital
Start
Jul 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of dexmedetomidine in cardiac disease (2 arms), sponsored by Guangdong Provincial People's Hospital Zhuhai Hospital. Primary endpoints: Interleukin-6, Tumor necrosis factor-alpha and 1 more. Started Jul 2019; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

cardiac disease

Beyond the preview

Go deeper on ChiCTR2000032652.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000032652.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call